Identifying Selective Antagonists for α1-Adrenoceptors
Author Information
Author(s): Emily S. Stoddart, Sevvandi Senadheera, Iain J. A. MacDougall, Renate Griffith, Angela M. Finch
Primary Institution: University of New South Wales
Hypothesis
Can we identify novel α1-AR subtype selective compounds using pharmacophores?
Conclusion
The study successfully identified a lead compound with α1A/D-AR selectivity and a novel structural scaffold for further drug development.
Supporting Evidence
- 12 compounds were selected based on diversity of structure and predicted high affinity.
- 9 out of 12 tested compounds displayed affinity at the α1A and α1D-AR subtypes.
- 6 compounds displayed affinity at all three α1-AR subtypes.
Takeaway
The researchers found new compounds that can block specific receptors in the body, which could help in making better medicines with fewer side effects.
Methodology
The study used virtual screening of compound databases with pharmacophores to identify selective antagonists.
Limitations
The training sets used for pharmacophore development lacked sufficient α1A/D-AR selectivity.
Statistical Information
P-Value
p<0.0005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website